The present disclosure relates to multi-component hydrogels. The hydrogels may include a natural component having nucleophilic functional groups as well as an electrophilic component. In embodiments, at least one of the components may be branched, having drugs, antibodies, enzymes, and the like inco
The present disclosure relates to multi-component hydrogels. The hydrogels may include a natural component having nucleophilic functional groups as well as an electrophilic component. In embodiments, at least one of the components may be branched, having drugs, antibodies, enzymes, and the like incorporated therein, which may react with at least one of the other components of the hydrogel.
대표청구항▼
1. A tissue scaffold comprising: a first hydrogel precursor comprising a natural component selected from the group consisting of collagen, serum, gelatin, hyaluronic acid, and combinations thereof;a second hydrogel precursor comprising an electrophilic functional group selected from the group consis
1. A tissue scaffold comprising: a first hydrogel precursor comprising a natural component selected from the group consisting of collagen, serum, gelatin, hyaluronic acid, and combinations thereof;a second hydrogel precursor comprising an electrophilic functional group selected from the group consisting of n-hydroxysuccinimides, succinimidyl succinates, succinimidyl propionates, sulfosuccinimides, isocyanates, thiocyanates, carbodiimides, benzotriazole carbonates, and combinations thereof; andat least one multi-armed polyethylene glycol functionalized with a component selected from the group consisting of bioactive agents, antibodies, enzymes, and combinations thereof,wherein the first hydrogel precursor and the second hydrogel precursor react to form the tissue scaffold. 2. The tissue scaffold of claim 1, wherein the natural component includes a nucleophilic functional group. 3. The tissue scaffold of claim 1, wherein the first hydrogel precursor is exogenous to a patient. 4. The tissue scaffold of claim 1, wherein the first hydrogel precursor is endogenous to a patient. 5. The tissue scaffold of claim 1, wherein the second hydrogel precursor comprises a polyethylene glycol having n-hydroxysuccinimide groups. 6. The tissue scaffold of claim 1, wherein the at least one multi-armed polyethylene glycol comprises the second hydrogel precursor. 7. The tissue scaffold of claim 6, wherein the at least one multi-armed polyethylene glycol has four arms. 8. The tissue scaffold of claim 1, wherein the first hydrogel precursor is present in an amount from about 1.5 to about 20 percent by weight of the tissue scaffold, and the second hydrogel precursor is present in an amount from about 0.5 to about 20 percent by weight of the tissue scaffold. 9. The tissue scaffold of claim 1, wherein the tissue scaffold further comprises at least one additional bioactive agent selected from the group consisting of stem cells, DNA, RNA, enzymes, growth factors, peptides, polypeptides, antibodies, and combinations thereof. 10. A method comprising: identifying a cartilage defect;cleaning out the cartilage defect;introducing into the defect a first hydrogel precursor comprising a natural component selected from the group consisting of collagen, serum, gelatin, hyaluronic acid, and combinations thereof; a second hydrogel precursor comprising an electrophilic functional group selected from the group consisting of n-hydroxysuccinimides, succinimidyl succinates, succinimidyl propionates, sulfosuccinimides, isocyanates, thiocyanates, carbodiimides, benzotriazole carbonates, and combinations thereof; and at least one multi-armed polyethylene glycol functionalized with a component selected from the group consisting of bioactive agents, antibodies, enzymes, and combinations thereof;allowing the first hydrogel precursor and the second hydrogel precursor to react to form a hydrogel,wherein the hydrogel forms a tissue scaffold at the site of the cartilage defect. 11. The method of claim 10, wherein the first hydrogel precursor is exogenously applied to the defect. 12. The method of claim 10, wherein the first hydrogel precursor is endogenous to the defect and the hydrogel is semi-autologous. 13. The method of claim 10, wherein the natural component is whole serum. 14. The method of claim 10, wherein the second hydrogel precursor comprises a polyethylene glycol having n-hydroxysuccinimide groups. 15. The method of claim 14, wherein the polyethylene glycol having n-hydroxysuccinimide groups has multiple arms. 16. The method of claim 15, wherein the polyethylene glycol having n-hydroxysuccinimide groups has four arms. 17. The method of claim 10, wherein the first hydrogel precursor is present in an amount from about 1.5 to about 20 percent by weight of the hydrogel, and the second hydrogel precursor is present in an amount from about 0.5 to about 20 percent by weight of the hydrogel. 18. The method of claim 10, wherein the hydrogel further comprises at least one bioactive agent selected from the group consisting of stem cells, DNA, RNA, enzymes, growth factors, peptides, polypeptides, antibodies, and combinations thereof. 19. The method of claim 10, wherein the first hydrogel precursor and the second hydrogel precursor are simultaneously applied to the defect. 20. The method of claim 10, wherein the first hydrogel precursor and the second hydrogel precursor are separately applied to the defect. 21. The method of claim 10, wherein the first hydrogel precursor and the second hydrogel precursor are sequentially applied to the defect. 22. A kit for the repair of tissue defects comprising: a first hydrogel precursor comprising a natural component selected from the group consisting of collagen, serum, gelatin, hyaluronic acid, and combinations thereof;a second hydrogel precursor comprising an electrophilic functional group selected from the group consisting of n-hydroxysuccinimides, succinimidyl succinates, succinimidyl propionates, sulfosuccinimides, isocyanates, thiocyanates, carbodiimides, benzotriazole carbonates, and combinations thereof; andat least one multi-armed polyethylene glycol functionalized with a component selected from the group consisting of bioactive agents, antibodies, enzymes, and combinations thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (49)
Sawhney,Amarpreet S., Adhesion barriers applicable by minimally invasive surgery and methods of use thereof.
Rhee Woonza M. ; Rao Prema R. ; Chu George H. ; DeLustro Frank A. ; Harner Carol F. H. ; Sakai Naomi ; Schroeder Jacqueline A., Biocompatible adhesive compositions.
Rhee Woonza M. ; Rao Prema R. ; Chu George H. ; DeLustro Frank A. ; Harner Carol F. H. ; Sakai Naomi ; Schroeder Jacqueline A., Biocompatible adhesive compositions.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Biologically inert, biocompatible-polymer conjugates.
Rhee Woonza M. (Palo Alto CA) Rao Prema R. (Los Gatos CA) Chu George H. (Cupertino CA) DeLustro Frank A. (Belmont CA) Harner Carol F. H. (Redwood Shores CA) Sakai Naomi (San Mateo CA) Schroeder Jacqu, Collagen-based bioadhesive compositions.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Implants coated with collagen-polymer conjugates.
Rhee Woonza M. ; Berg Richard A. ; Chu George H. ; DeLustro Frank A. ; Jolivette Dan M. ; McCullough Kimberly A., Injectable or implantable biomaterials for filling or blocking lumens and voids of the body.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Method of augmenting tissue with collagen-polymer conjugates.
Rhee Woonza M. (Palo Alto CA) Berg Richard A. (Los Altos CA) Rosenblatt Joel S. (Palo Alto CA) Tefft Jacqueline A. (Redwood City CA) Braga Larry J. (Fremont CA) Smestad Thomas L. (Palo Alto CA), Method of preparing crosslinked biomaterial compositions for use in tissue augmentation.
Sehl, Louis C.; Trollsas, Olof Mikael; Wallace, Donald G.; Toman, David; DeLustro, Frank A.; Schroeder, Jacqueline A.; Chu, George H., Methods for tissue repair using adhesive materials.
Hubbell Jeffrey A. (Austin TX) Pathak Chandrashekhar P. (Waltham MA) Sawhney Amarpreet S. (Newton MA) Desai Neil P. (Los Angeles CA) Hill Jennifer L. (Austin TX), Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.